Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Market Vectors Biotech ETF

+ Add to Watchlist

BBH:US

123.3700 USD 1.4100 1.16%

As of 20:04:02 ET on 01/29/2015.

Snapshot for Market Vectors Biotech ETF (BBH)

Open: 121.7300 High - Low: 123.4700 - 120.4900 Primary Exchange: NYSE Arca
Volume: 203,069 52-Week Range: 80.0500 - 126.0850 Beta vs MVBBHTR: 1.0010

ETF Chart for BBH

No chart data available.
  • BBH:US 123.3700
  • 1D
  • 1M
  • 1Y
121.9600
Interactive BBH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BBH

Market Vectors Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to track the performance of the US Listed Biotech 25 Index.

Inception Date: 2011-12-21 Telephone: 1-212-293-2000
Managers: PETER LIAO / GEORGE CAO
Web Site: www.vaneck.com

Fundamentals for BBH

NAV (on 2015-01-29) 123.3202
Assets (M) (on 2015-01-29) 727.1579
Shares out (M) 5.90
Market Cap (M) 727.45
% Premium 0.04
Average 52-Week % Premium -0.0036
Fund Leveraged N

Dividends for BBH

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2013-12-23) 0.0030
Dividend Yield (ttm) 0.00%

Performance for BBH

1-Month +4.60% 1-Year +27.23%
3-Month +6.47% 3-Year +42.05%
Year To Date +5.70% 5-Year -
Expense Ratio 0.35

Top Fund Holdings for BBH

Filing Date: 01/28/2015
Name Position Value % of Total
Gilead Sciences Inc 964,652 98,828,597 13.729%
Amgen Inc 535,709 82,842,040 11.508%
Celgene Corp 651,455 77,503,601 10.766%
Biogen Idec Inc 146,794 51,551,117 7.161%
Illumina Inc 171,527 33,938,332 4.715%
BioMarin Pharmaceutical Inc 344,997 33,550,958 4.661%
Vertex Pharmaceuticals Inc 269,501 32,679,691 4.540%
Alexion Pharmaceuticals Inc 183,205 32,570,185 4.525%
Incyte Corp 378,810 30,850,286 4.286%
Regeneron Pharmaceuticals Inc 74,652 30,458,016 4.231%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil